Should radial artery access be the "gold standard" for PCI?

Heart

Volumn 94, Issue 12, 2008, Pages 1530-1532

  Hamon, Martial ^a   Nolan, James ^b  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; THIENOPYRIDINE DERIVATIVE; TROPONIN;

ACUTE CORONARY SYNDROME; ANEMIA; ARTERIOVENOUS FISTULA; BLEEDING; CLINICAL FEATURE; CORONARY STENT; DIAGNOSTIC PROCEDURE; EDITORIAL; FALSE ANEURYSM; FEMORAL ARTERY; HEART MUSCLE ISCHEMIA; HEMATOMA; HUMAN; LABORATORY TEST; LEFT ANTERIOR DESCENDING CORONARY ARTERY; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RADIAL ARTERY; RETROPERITONEAL HEMORRHAGE; TREATMENT OUTCOME; VASCULAR ACCESS;

ACUTE CORONARY SYNDROME; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; RADIAL ARTERY; RISK FACTORS;

EID: 56849129070     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.148379     Document Type: Editorial

References (27)

1. Chase AJ, Fretz EB, Warburton WP, et al. Association of arterial access site at angioplasty with transfusion and mortality. The M.O.R.T.A.L study: (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg). Heart 2008;94:1019-25.
2. Kinnaird TD, Stabile E, Mintz G, et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 2003;92:930-5.
3. Steinhubl SR, Kastrati A, Berger PB. Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs. Am Heart J 2007;154:3-11.
4. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-st-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the management of patients with unstable angina/non-st-elevation myocardial infarction). J Am Coll Cardiol 2007;50:1-157.
5. Bassand J, Hamm CW, Ardissino D, et al. Guidelines for the Diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society and Cardiology. Eur Heart J 2008;28:1598-660.
6. Nikolsky E, Mehran R, Halkin A, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol 2004;44:1200-9.
7. Malik I. Closure devices from femoral punctures. Heart 2008;94:547-8.
8. Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004;292:1555-62.
9. Yang X, Alexander KP, Chen AY, et al. The implications of blood transfusions for patients with non-ST segment elevation acute coronary syndromes. Results from the crusade national quality improvement initiative. J Am Coll Cardiol 2005;46:1490-5.
10. Manoukian S, Feit F, Mehran R, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes. An analysis from the ACUITY trial. J Am Coll Cardiol 2007;49:1362-8.
11. Yusuf S, Mehta SR, Chrolavicius S, et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006;354:1464-76.
12. Hamon M, Filippi-Codaccioni E, Riddell JW, et al. Prognostic impact of major bleeding in patients with acute coronary syndromes. A systematic review and meta-analysis. Eurointervention 2007;3:400-8.
13. Agostoni P, Biondi-Zoccai GGL, de Benedictis I, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures. Systematic ovverview and interventional procedures. J Am Coll Cardiol 2004;44:349-56.
14. Montalescot G, Ongen Z, Guindy R, et al. Predictors of outcome in patients undergoing PCI. Results of the RIVIERA study. Int J Cardiol 2007 Dec 3 [Epub ahead of print].
15. Stone GW, McLaurin BT, Cox DA, et al. Prospective, randomized comparison of heparin plus glycoprotein IIb/IIIa inhibition and bivalirudin with or without glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes: the ACUITY trial. N Engl J Med 2006;355:2203-16.
16. Eccleshall SC, Banks M, Carroll R, et al. Implementation of diagnostic and interventional transradial programme: resource and organisational implications. Heart 2003;89:561-2.
17. Lo TSN, Hall IR, Jaurndally H, et al. Transradial rescue angioplasty for failed thrombolysis in acute myocardial infarction: reperfusion with reduced vascular risk. Heart 2006;92:1153-4.
18. Lo TSN, Buch A, Hall IR, et al. Percutaneous left and right heart catheterisation in fully anticoagulated patients utilising the radial artery and forearm veins: a two centre experience. J Interven Cardiol 2006;19:258-63.
19. Kiemeneij F, Laarman GJ, Oderkerken D, et al. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. J Am Coll Cardiol 1997;29:1269-75.
20. Brasselet C, Tassan S, Nazeyrollas P, et al. Randomized comparison of femoral versus radial approach for percutaneous coronary intervention using abxicimab in acute myocardial infarction: Results of the FARMI trial. Heart 2007;93:1556-61.
21. Ali A, Hashem M, Rosman HS, et al. Glycoprotein IIb/IIIa receptor antagonists and risk of bleeding: a single-center experience in 1020 patients. J Clin Pharmacol 2004;44:1328-32.
22. Eikelboom JW, Shamir RM, Anand SS, et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006;114:774-82.
23. Feit F, Voeltz MD, Attubato MJ, et al. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol 2007;100:1364- 9.
24. Lenderink T, Boersma E, Ruzyllo W et al. Bleeding events with abciximab in acute coronary syndromes without early revascularization: an analysis of GUSTO IV-ACS. Am Heart J 2004;147:865-73.
25. Moscucci M, Fox KAA, Cannon CP, et al. Predictors of major bleeding in acute coronary syndromes: the global registry of acute coronary events (GRACE). Eur Heart J 2003;24:1815-23.
26. Rao SV, O'Grady K, Pieper KS et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 2005;96:1200-6.
27. Segev A, Strauss BH, Tan M, et al. Predictors and 1-year outcome of major bleeding in patients with non-ST-elevation acute coronary syndromes: insights from the Canadian acute coronary syndromes registries. Am Heart J 2005;150:690-4.